These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37800812)

  • 21. Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy.
    Wang S; Qin S; Cai B; Zhan J; Chen Q
    Front Endocrinol (Lausanne); 2023; 14():932649. PubMed ID: 37522131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
    Peng L; Chen Y; Shi S; Wen H
    Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules.
    Tang J; Liu F; Cooper ME; Chai Z
    Expert Opin Ther Targets; 2022 Aug; 26(8):721-738. PubMed ID: 36217308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
    Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
    PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
    Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
    Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
    Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
    Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of diabetic nephropathy: Recent progress and future perspective.
    Ahmad J
    Diabetes Metab Syndr; 2015; 9(4):343-58. PubMed ID: 25845297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.
    Samsu N
    Biomed Res Int; 2021; 2021():1497449. PubMed ID: 34307650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling.
    Gupta S; Sen U
    Pharmacol Res; 2019 Sep; 147():104391. PubMed ID: 31401210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy.
    Ji J; Tao P; Wang Q; Li L; Xu Y
    Endocr Metab Immune Disord Drug Targets; 2021; 21(5):835-842. PubMed ID: 33121427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
    Sutariya B; Saraf M
    J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging therapeutics for the treatment of diabetic nephropathy.
    Brenneman J; Hill J; Pullen S
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4394-4402. PubMed ID: 27520943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.
    Lv M; Chen Z; Hu G; Li Q
    Drug Discov Today; 2015 Mar; 20(3):332-46. PubMed ID: 25448752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism.
    Hu X; Liu W; Yan Y; Liu H; Huang Q; Xiao Y; Gong Z; Du J
    Eur J Pharmacol; 2019 Feb; 845():91-98. PubMed ID: 30287151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA NONHSAG053901 promotes diabetic nephropathy via stimulating Egr-1/TGF-β-mediated renal inflammation.
    Peng W; Huang S; Shen L; Tang Y; Li H; Shi Y
    J Cell Physiol; 2019 Aug; 234(10):18492-18503. PubMed ID: 30927260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
    Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
    Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target.
    Chen J; Liu Q; He J; Li Y
    Front Immunol; 2022; 13():958790. PubMed ID: 36045667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.
    Hunsicker LG
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S12-7. PubMed ID: 15369420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.